Published Date: 06 Mar 2023
In a new study, researchers report the use of inhaled corticosteroids (HFNC) in patients with mild to moderate bronchiolitis...
Read Full NewsQ&A: Discussing 2027 GOLD Report Updates in COPD, With David Singh, MD
The HCPFive: Top News for Healthcare Providers from the Week of 11/1
Catch up on any of the neurology headlines you may have missed in October 2026, compiled into 1 place by the NeurologyLive® team.
Interim phase 1b data showed cizutamig produced rapid, sustained improvement in generalized myasthenia gravis with no cases of cytokine release syndrome.
SHASTA-3/4: Plozasiran Could Cut Acute Pancreatitis Risk by 78% Across sHTG Spectrum
Bimekizumab Ranks First in HS Network Meta-Analysis of 17 Trials
Unmet Needs in HS and Emerging Oral Options, With Martina Porter, MD
1.
Medicaid expansion tied to smaller declines in early-stage cancer detection
2.
A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML
3.
All-Oral Treatment Combo for AML Earns FDA Nod
4.
Could the Prostate Cancer Story of Francis Collins Dissuade Men from Active Surveillance?
5.
For patients with prostate cancer, long-term follow-up helps identify treatment side effects.
1.
Developmental Platelet Biology in Childhood: Clinical Implications and Advances
2.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
3.
Guidelines for Treatment Sequencing in Advanced Cancer
4.
Patient Management After Personalized Surgical Oncology Reconstruction
5.
Cellular Mechanisms of Hematopoietic Stress Adaptation During Repeated Physiological Demand
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
When Unexplained Bruising May Require Blood Testing
2.
Efficient Management of First line ALK-rearranged NSCLC - Part II
3.
Managing Supportive Care During Platelet Recovery
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation